Change the world

J2HBiotech - Journey to Healthcare Solutions

R&D Center

R&D Center : At the Heart of Innovation

At J2H Biotech, our R&D Center plays a central role across the entire drug development process—from early-stage research to candidate discovery and optimization—supported by cutting-edge research infrastructure.Through the discovery of novel drug candidates, non-clinical studies, and platform technology development, we provide a globally competitive research environment and serve as a driving force behind the creation of innovative therapies.

R&D Center image01R&D Center image02R&D Center image03R&D Center image04
Previous
Next

Drug Development Strategy : A Balanced R&D Portfolio

J2H Biotech pursues sustainable growth through a well-balanced R&D strategy, carefully managing risk, return, and development speed.

Image

Detail View
  1. 01
    First in Class
    (High Risk)
    • - Development of innovative therapies targeting novel pathways for rare and incurable diseases
    • - While early-stage risks are high, successful outcomes offer significant impact and returns
  2. 02
    Fast Followers
    (Medium Risk)
    • - Addressing the limitations of existing drugs to enable faster market entry
    • - Leveraging solid data for early-stage out-licensing opportunities (L/O)
  3. 03
    Hybrids
    (Medium-Low Risk)
    • - Focus on improved drugs (API-based) to enable rapid commercialization and consistent revenue generation
    • - Evaluating commercialization pathways to maintain stable cash flow
  4. 04
    Early Birds
    (Low Risk)
    • - Rapid commercialization with minimal risk
    • - Achieving early market penetration by bypassing existing patents

Strategic Differentiation and Objectives

  • Balancing Risk and Return
    Maximizing success potential through balanced investments
  • Speed Optimization
    Enhancing R&D efficiency with accelerated development and market strategies
  • Solving Unmet Medical Needs
    Improving patient outcomes and addressing rare and incurable diseases

Through strategic portfolio management, J2H Biotech ensures sustainable growth,
strengthens global competitiveness, and continues its mission to enhance the quality of life for patients worldwide.

Patent Achievements : Strengthening Global Competitiveness in Innovative Drug Development

J2H Biotech has built a robust patent portfolio based on world-class R&D capabilities and innovative technologies.
These patents serve as critical assets, reinforcing our technical competitiveness and long-term sustainability.

  • Patent Applications (South Korea)

    57

  • Patents Granted (South Korea)

    17

  • PCT Applications (International)

    24

  • Patents Granted (International)

    35

J2H Biotech leverages its proprietary OPTIFLEX® platform to secure unique patents that enhance our global competitiveness in drug development. Our key patents cover technologies and novel drug candidates for treating rare and incurable diseases, oncology, and anti-fibrosis. These patents create opportunities for strategic partnerships and licensing (L/O), solidifying our position in the global biopharmaceutical market.